Here we were able to show the association between aPKC expression level and the presence of pSer218-FoxO1 staining and patient survival and that aPKC inhibitors can affect angiosarcoma proliferation in vitro, hence, our results present a potential diagnostic strategy and may open a therapeutic opportunities for angiosarcoma. This evidence concerns the gene FOXO1 and angiosarcoma.